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BmAgmwmL In patients with imbentic left ventricular dysfunc-
sm, uptuake may be reduced in some
0,wardild regions despite normal flow. The significance of this
is unclear and has not been Investigated systematically .
Mwa*Wds . Twenty-three patients with coronary artery disease
mW Impaired ventricular function (mean ejection fraction
[*I 8D] 23 * 10%) underwent positron emission tomography
with ' OF-fluomleoxyglucose and oxygen-15-labeled water at rest,
exercise thafflum-201 tomographic Imaging with rest reinjection
matl pMA nmpdk rnamoanauKae Imaging to measure end-diastolic
wall thickness and systolic wall thickening .
Resub. Of 168 regions with normal flow (z!0 .7 mUg per min),
125 (74%) had normal ' IF-flu orodeoxyglucose uptake (98 :t
10%), and the remaining 4.1(26%) showed moderately reduced
"F-fluorWeOxyglacm uptake (69 * 8%) . Systolic wall thicken-
Metabolic imaging with positron emission tomography using
'"F-fluxrodeoxyglucose has been reported to distinguish
among normal, ischemic and fibrotic myocardium in patients
with chronic coronary artery disease and left ventricular
dysfunction (1-5). This differentiation is based on the rela-
tion between regional blood flow and glucose metabolism . In
particular, myocardial regions with normal blood flow are
considered to represent normal myocardium regardless of
the magnitude of "aF .fluorodeoxyglucose uptake in those
territories. In contrast, myocardial regions with reduced
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lug was absent at rest in 14% of regions with normal 18F-
fluorodeoxyglucose uptake compare with 32% of regions with
reduced 'IF-fluorodeoxyglucose uptake (p < 0 .01). Reversible
thallium abnormalities were observed in 45 (36%) of 125 regions
with normal 181E-fluorodeoxyglucose uptake compared with 27
(63%) of 43 regions with reduced 'O F-fluorodeoxyglucose uptake
(p < 0.01). This difference was accounted for by a higher
proportion of partially reversible defects in regions with reduced
'IF-fluorodeoxyglucose uptake compared with regions with nor-
mal ' OF-fluorodeoxyglucose uptake (42% vs. 18%, respectively,
p < 0.01).
Conclusions . Thus, regions with moderately reduced 'OF-
fluorodeoxyglucose uptake with normal flow occur commonly in
patients with Ischemic left ventricular dysfunction . The majority
of these regions show impaired systolic function at rest and
exercise-induced thallium abnormalities that are only partially
reversible. These observations suggest that such regions rep nt
en Admixture of fibrotic and reversibly ischemic myocardium .
(J Am Coll Cardiol 1994,23 .608-16)
blood flow are considered to represent either ischemic
myocardium, when ' 8F-fluorodeoxyglucose uptake is in-
creased relative to flow ( 18 F-fluorodeoxyglucese-blood flow
mismatch), or nonviable myocardium, when both blood flow
and ' 8F-fluorodeoxyglucose uptake are proportionately re-
duced (1-5) . However, in patients with coronary artery
disease, myocardial territories with normal blood flow may
occasionally manifest a reduction in ' OF-fluorodeoxyglucose
uptake, which is apparent even in the glucose-loaded
state when the physiologic inhomogeneity in glucose uptake
is minimal (6) . Although these territories are convention-
ally assumed to represent normal myocardium, because
blood flow is normal, the causes of the reduced 18F-
fluorodeoxyglucose uptake are unknown and its functional
characteristics have not been investigated . Therefore, the
aim of this study was to assess the functional characteristics
and the response to exercise of myocardial regions with
normal blood flow and reduced 18F-fluorodeoxyglucose up-
take and to compare these characteristics with those of
myocardial regions with normal blood flow and normal
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JACC Vol. 23, No . 3
March 1, 1994 .608-16
	
MYOCARDIAL BLOOD FLOW AND REDUCED GLUCOSE
UPTAKE
' 8F-fluorodeoxyglucose uptake ii, nctients with chronic cor-
onary artery disease and left ventricular dysfunction .
Methods
Patient selection. We studied 23 patients with angiograph-
ically proved coronary artery disease and left ventricular
dysfunction . There were 22 men and 1 woman ranging in age
from 45 to 78 years (mean 59 ± 9) . Mean left ventricular
ejection fraction by radionuclide angiography was 28 ± 10%
at rest. Although all patients had evidence of previous
myocardial infarction, we studied only patients with chronic
stable coronary artery disease . No patient had an acute
myocardial infarction or unstable angina within 6 months of
the study, and no patient had diabetes mellitus . The glucose
plasma level before the ' 8F-fluorodeoxyglucose study (ob-
tained in 20 of the 23 patients) was in the normal fasting
range (96 ± 19 mg/WY Coronary arteriography demonstrated
significant stenosis (~5O% reduction in lumen diameter) of
all three major epicardial coronary arteries in 14 patients and
of two coronary arteries in 6 patients . All patients underwent
radionuclide angiography, positron emission tomography,
thallium-201 single-photon emission computed tomography
and gated magnetic resonance imaging . in 19 patients all
cardiac medications were discontinued for >48 h before
radionuclide angiography, thallium-201 positron emission
tomography and magnetic resonance imaging were per-
formed. An average of 27 ± 27 days elapsed between
performance of the first and the last of these tests . Positron
emission tomography and thallium data in relation to re-
gional systolic function have been reported previously in
these patients (7) . Written informed consent for the protocol
was obtained in each case. The protocol was approved by
the National Heart, hung, and Blood Institute Clinical
Research Subpanel on March 1989 (protocol 86-H-209) . The
estimated radiation exposure did not exceed 1 .3811 total
body dose .
Study protocol . Gated blood pool cardiac scintigraphy .
Gated equilibrium radionuclide angiography was performed
at rest with the patients in the supine position using red
blood cells labeled in vivo with 20 to 25 mCi of technetium-
99m. High temporal resolution (20-ms/frame) time-activity
curves were generated, from which the left ventricular
ejection fraction and time to end-systole were computed, as
previously described (8) .
Thallium imaging, All patients
underwent exercise thal-
lium single-photon emission computed tomography, as pre-
viously described (9) . In brief, after an overnight fast,
patients underwent treadmill exercise according to a stan-
dardized multistage exercise protocol, with continuous mon-
itoring of heart rate and rhythm, blood pressure and symp-
toms. At peak exercise, 2 mCi of thallium-201 was injected
intravenously, and the patients continued exercise for an
additional 45 to 60 s . Approximately 10 min after termination
of exercise, thallium images were obtained using a wide field
of view rotating gamma camera equipped with a high sensi-
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tivity, medium resolution, parallel hole collimator centered
on the 68-keV photo peak with a 20% window . The camera
was rotated in a 180° arc in an elliptic orbit about the
patient's shoulders across the thorax from a right anterior
oblique angle of 40° to a left posterior oblique angle of 40° to
6° increments for 30 s each (9) .
Redistribution images were obtained 3 to 4 h after stress
while the patients were resting . Immediately thereafter all
patients received an additional I mCi of thallium, and
tomographic images were acquired 10 to 15 min later . The
exercise, redistribution and reinjection data were recon-
structed as a series of whole body transaxial tomograms for
direct comparison with the corresponding positron emission
and magnetic resonance tomograms, as described later .
Single-photon emission computed tomography in plane and
z axis resolution was approximately 12 mm . Data were
reconstructed with 6 .88 mm per pixel sampling and with a
6.88-mm separation between slices .
Positron emission tomography . Positron emission to-
mography was performed, as previously described (7,10), to
assess regional myocardial perfusion with oxygen-15-
labeled water (H
2
15 0) and exogenous glucose utilization
with 18F-fluorodeoxyglucose using a whole body positron
emission tomography camera producing 21 contiguous tomo-
grams spaced 5 .1 mm apart with a slice thickness of 13 mm
and an in-plane reconstructed resolution of 6 .5 mm. Images
were obtained perpendicular to the long axis of the body to
create a series of transaxial tomograms . After an overnight
fast, all patients were pretreated with 50 g of oral glucose I h
before the ' 8F-fluorodeoxyglucose study . An attenuation
scan was performed, and then two separate bolus injections
of 12 to 15 mCi of H 2 150 were administered intravenously
12 min apart, followed by the administration of 5 mCi of
"F-f,uorodeoxyglucose 15 min later . Data were acquired
for 5 min in list mode after each water injection and for 60
to 75 min in list mode after the ' 8F-fluorodeoxyglucose
injection. The data beginning at 30 min after ' 8F-
fluorodeoxyglucose injection, corresponding to the final 30
to 45 min of data acquisition, were reconstructed to cre-
ate tomographic images of regional myocardial ' 8F-
fluorodeoxyglucose uptake . To prevent chest movement,
two seat belts were fastened around the patient's thorax
during the acquisition of the study .
Magnetic resonance imaging . Electrocardiographic
gated magnetic resonance imaging (MRI) was performed
using a 1 .5 tesla scanner . A 15- to 20-min scan allowed
acquisition of four to five slices at four to five time points in
the cardiac cycle from end-diastole to end-systole using spin
echo imaging (echo time = 20 ms ; repetition time = R wave
to R wave time, two excitations) . Each slice was 10 mm
thick, with a center to center slice distance of 20 mm .
Immediately after this acquisition, a second acquisition was
begun, again consisting of four to five slices at four to five
time points to fill in the gaps between slices . The final image
sequence therefore consisted of 8 or 10 contiguous slices
(10 mm thick, 10-mm center to center interstice distance) at
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four to five time points in the cardiac cycle from end-diastole
to end-systole. Total time was 30 to 45 min .
The time to end-systole was determined before MR11
studies from the left ventricular volume curve obtained from
the radionuclide ventriculogram that was acquired at a
similar heart rate. To obtain the end-systolic image, the
intersequence delay of the MRI study (i .e ., the time interval
between successive time points) was adjusted so that the last
(fourth or fifth) time point of the MRI study occurred at
end-systole, as determined from the radionuclide study .
Nuta aunlysis . In each patient, corresponding transaxial
tomograms from the three sets of thallium images represent-
ing the exercise, redistribution and rcir&ction studies were
visually aligned for direct comparison (7,10) . These in turn
were aligned with the corresponding transaxial tomographic
images of myocardial "F-fluorodeoxyglucose uptake from
the positron emission tomography study . To avoid errors
stemming from the reslicing process of three different imag-
ing approaches, only transaxial images were analyzed .
Therefore, considering the difficulty of assessing the inferior
myocardial wall using the transaxial plane, only correspond-
ing midventricular positron emission, thallium and mag-
netic resonance myocardial tomograms were used for the
analysis. To objectively compare relative regional ' 8F-
fluorodeoxyglucose and thallium activity, five myocardial
regions of interest representing the posterolateral, anterolat-
eral, anteroapical, anteroseptal and posteroseptal myocar-
dium were drawn on each 18F-fluorodeoxyglucose tomogram
and on each of the three corresponding thallium images .
Regional "F-fluorodeoxyglucose and thallium activities
(nCi/ml) were then computed within each region of interest
(7,10) .
Wall thickness measurements. To assess regional end-
diastolic wall thickness and absolute wall thickening, corre-
sponding transaxial end-diastolic and end-systolic magnetic
resonance images were analyzed by two independent oper-
ators unaware of the thallium and '"F-fluorodeoxyglucose
results. Alignment of the positron emission tomograms with
the corresponding magnetic resonance tomograms was done
visually using both the positron attenuation images (that
show the lung outlines, the heart shadow and the slice in
which the liver first begins to appear) and the positron
emission images. Because of the different interslice distance
(5.1 mm for positron emission tomography and 10 mm for
MRI studies), each magnetic resonance tomogram was
matched with two contiguous positron emission tomograms .
An average of three magnetic resonance slices and 6 18F-
fluorodeoxyglucose and thallium tomographic planes were
analyzed for each patient . As described earlier, each
positron emission tomography and thallium slice had been
divided into five regions of interest . By appropriate scaling
and resampling, the positron emission tomography and mag-
netic resonance images were made to be of identical size
(i .e ., the same number of millimeters per pixel) . The five
regions of interest drawn on the positron emission tomo-
grams could then be superimposed visually on the magnetic
JACC Vol. 23, No. 3
resonance tomograms, with appropriate rotations and trans-
lations also determined visually . Because each region of
interest encompassed a relatively large amount of myocar-
dial tissue, minor misalignments using this visual technique
would not significantly alter the results . Thickness measure-
ments were made from the MRI data at the center of each
region of interest by manually identifying a point on the
epicardial and endocardial borders perpendicular to the two
surfaces. The length of the line segment joining these two
points was calculated and considered as the wall thickness .
Systolic wall thickening was defined as the difference be-
tween end-systolic and end-diastolic wall thicknesses . Ac-
cording to the extent of systolic wall thickening (11), myo-
cardial regions were considered normokinetic (systolic wall
thickening ~2 mm) . hypokinetic (systolic wall thickening
<2 mm) or akinetic-dyskinetic (absent wall thickening or
systolic wall thinning) .
Regional myocardial thallium activity . In each patient
the myocardial region of interest with the maximal counts on
the exercise thallium study was used as the normal reference
region for that patient (7,10). The corresponding anatomic
regions in the redistribution and reinjection studies were
identified and used as the reference regions for those studies .
The thallium activity in all other myocardial regions was
then expressed as a percent of the activity measured in the
reference region for each of the exercise, redistribution and
reinjection image series .
For each exercise study, thallium activity in any myocar-
dial region that measured <85% of the normal reference
region was considered reduced and defined ass a thallium
perfusion defect (7,10) . On the basis of previous reproduc-
ibility studies from our laboratory (12), a regional thallium
abnormality during exercise was considered reversible if the
relative thallium activity increased by ? 10% on the subse-
quent redistribution or reinjection images . A defect was
considered completely reversible if this increase resulted in
thallium activity that was >85% of the activity in the
reference region . Similarly, thallium abnormalities during
exercise were considered irreversible if the relative thallium
activity was unchanged or increased < 1001 on the subse-
quent redistribution and reinjection images. In addition, a
defect on exercise images was also considered irreversible if
the activity in that region remained <50% of the activity in
the normal reference region after redistribution and reinjec-
tion . On the basis of the relative regional thallium activity on
the exercise images, thallium defects that were irreversible
on redistribution and reinjection images were classified as
mild to moderate (51% to 85% of peak activity) or severe
( :55en of peak), as previously described (7,10,12) .
Regional myocardial blood flow. We computed absolute
regional myocardial blood flow from the dynamic H2'50 data
(13). The myocardial regions of interest previously con-
structed on the
18
F-fluorodeoxyglucose images for measure-
ment of regional
18
F-fluorodeoxyglucose activity were ap-
plied to the tomographic H 2150 data to derive regional
myocardial H2'50 time-activity curves . Absolute regional
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where the parameters of the fit are PV (a partial volume
correction factor), F (flow in mI/g per min) and SO (a
spillover correction factor, indicating the fraction of counts
spilling from the left ventricular cavity into the myocardi-
um); x is the co9volutior, operation, and t is time . The
partition coefficient p was assumed fixed at 0 .92, and the
arterial input function, LV(t) was measured directly from
the left ventricular blood pool using the positron emission
tomographic data . Contamination from the myocardium was
carefully avoided by inspecting both the end-diastolic and
end-systolic corresponding magnetic resonance tomograms .
This approach is similar to the method of lida et al . (14) .
Bergamlin et al . (15) and Herrero et al . (16) except that our
fitting was weighted with the data's inverse variance, as
determined from total counts . deadtime and random correc-
tion factors. The computation of blood flow values was
performed twice, one for each 1-1 2 150 study, and the results
of the two measurements were then averaged together . The
average SD of the blood flow measurements was 0.22
0.18 ml/g per min .
The equation used to calculate blood flow also yields the
recovery coefficient for correction for partial volume ef-
fects. The recovery coefficient obtained form the water
data is also valid for the 18 F-fluorodeoxyglucose data ex-
tracted from the same regions of interest . The ' 8 F-
fluorodeoxyglucose data were analyzed both with and with-
out the correction for partial volume effects. Because a
similar correction could not be made for the thallium data .
the 18F-fluorodeoxyglucose and thallium comparisons were
made with neither data set corrected for recovery coefficient
in order not to bias the results .
Regional myocardial 18F-fluorodeoxyglucose uptake .
The myocardial region on the
18
F-fluorodeoxyglucose series
that corresponded to the normal reference region on the
thallium exercise image series was used as the normal
reference region for relative ' 8 F-fluorodeoxyglucose uptake .
The
18
F-fluorodeoxyglucose uptake in all other myocardial
regions was expressed as a percent of the activity in this
reference region (7,10) . The 23 regions defined as normal
reference regions for the 23 patients all showed normal blood
flow (1.0 ± 0.2 ml/g per min) and normal systolic wall
thickening (3 .7 ± 2.7 mm) .
Regional "F-fluorodeoxyglucose uptake relative to blood
flow. Myocardial regions with normal blood flow were de-
fined as those in which blood flow was >O .7 ml/g per min
(17) . In light of the variability reported by Gropler et al . (6)
in normal persons, "F-fluorodeoxyglucose uptake in each
patient was considered reduced when it measured <80% of
that of the normal reference region for that patient . Myocar-
dial regions with normal blood flow were then divided into a
group with normal 18F-fluorodeoxyglucose uptake and a
8
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Figure 1 . Blood flow, "F-fluorodeoxyglucose (FDG) activity and
end-diastolic wall thickness in myocardial regions with normal
regional blood flow and either normal or reduced "F-
fluorodeoxyglucose uptake
.
group with a moderate reduction in "F-fluorodeoxy&cose
uptake (50% to 79% of that of the normal region) .
Statistical analysis. The two-tailed unpaired Student t test
was applied for comparisons between the two groups . The
chi-square test was applied to compare percent data . The
reported correlations were analyzed by linear regression
analysis . All data are expressed as mean value ± SD . A
p value < 0.05 was accepted as the minimal level of
significance .
Results
One hundred sixty-eight myocardial regions showed nor-
mal blood flow at rest (~!0 .7 ml/g per min) . Of these, 125
regions (74%) had normal "'F-fluol -odeoxyglucose uptake
(98 ± 10%), and the remaining 43 regions (26%) showed
reduced
18
F-fluorodeoxyglucose uptake (69 ± 8%) . Among
the 43 regions with reduced "F-fluorodeoxyglucosc uptake,
19 (44%) were localized in the lateral wall, 12 (28%) in the
septum and 12 (28%) in the apex. Myocardial regions with
reduced "'F-fluorodeoxyglucose uptake and normal blood
flow were observed in 15 (65%) of the 23 patients . Ten of
these 15 patients had three-vessel coronary artery disease, 4
had two-vessel and I had one-vessel coronary artery dis-
ease . Of the 43 regions with normal blood flow and reduced
18 F-fluorodeoxyglucose uptake, 41 (95%) were localized in
the territory of a significantly stenosed vessel . Myocardial
blood flow was similar between regions with normal or
reduced 18 F-fluorodeoxyglucose uptake (Fig . 1) . In all myo-
cardial regions with normal blood flow there was no cor-
relation between blood flow and the amount of ' 8 F-
fluorodeoxyglucose activity (r = 0 . 19, p = NS) .
Regional anatomy and systolic function . Fluorine-18-
fluorodeoxyglucose activity did not correlate with end-
diastolic wall thickness (r = -0.04)
. End-diastolic wall
thickness did not differ between myocardial regions with
normal or reduced 18
F-fluorodeoxyglucose uptake (Fig . 0 .
myocardial blood flow was calculated by fitting the myocar-
dial H,`O time-activity curve, M(0, to the formula :
M(t) = RVHFHLVU) X e"M + 00)(A00,
1 -1
I ()
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When systolic wall thickening was evaluated in individual
regions, akinesia or dyskinesia was observed in 14 (32%) of
43 regions with reduced '"F-fluorodeoxyglucose compared
with only 18 (l4%) of 125 regions with normal '"F-
fluorodeoxyglucose uptake (p < 0.01, Fig . 2) . No correlation
between '"F-fluorodeoxyglucose activity and systolic wall
thickening was observed in all myocardial regions with
normal blood flow (r = 0.10, p = NS) or in the group of
regions with reduced '8F-fluorodeoxyglucose uptake (r =
0.21, p = NS). In both groups of myocardial regions with
normal or reduced "F-fluorodeoxyglucose uptake, no differ-
ence in '"F-fluorodeoxyglucose activity was found between
regions with normal or impaired wall thickening (95 ± 7% vs .
95 ± 7% in regions with normal '"F-fluorodeoxyglucose
uptake and 68 ± 8% vs . 68 ± 8% in regions with reduced
'"F-fluorodeoxyglucose uptake .
When the partial volume correction factor derived from
the En"O data was applied to the '"F-fluorodeoxyglucose
measurements, '"F-fluorodeoxyglucose activity was con-
firmed to be reduced in 29 (67%) of the 43 regions with
reduced uncorrected '"F-fluorodeoxyglucose activity, and
11(38%) of these 29 regions showed absent wall thickening .
RegWW thallium activity. Fifty-one (41%) of 125 myo-
cardial regions with normal '"F-fluorodeoxyglucose uptake
had normal thallium activity during exercise (Fig . 3) com-
pared with only 6 (14%) of 43 regions with reduced '"F-
fluorodeoxyglucose uptake (p < 0 .01). Reversible thallium
defects were observed in 45 (361%) of 125 regions with normal
'"F-fluorodeoxyglucose uptake and in 27 (63%) of 43 regions
with reduced '"F-fluorodeoxyglucose uptake (p < 0.01).
Systolic wall thickening was impaired in 17 (63%) of these
27 regions. An example of the finding of reduced '"F-
fluorodeoxyglucose in a region with normal blood flow but
reduced wall thickening and a reversible thallium defect is
shown in Figure 4 . The difference in the frequency of
reversible thallium defects was accounted for by a higher
Figure 2. Systolic wall thickening at rest in myocardial
regions with normal regional blood flow and either nor-
mal or reduced ' OF-fluorodeoxyglucose uptake. The
percent of regions with akinesia or dyskinesia was
significantly higher in the group with reduced "F-
fluorodeoxyglucose uptake. Abbreviations as in Figure 1 .
Figure 3 . Exercise thallium-201 findings in regions with normal regional
blood flow Lt rest and either normal or reduced "F-fluomdeoxyglucose
uptake. Myocardial regions with reduced "F-fluorodeoxyglucose uptake
had a lower likelihood of normal thallium uptake on single-photon positron
emission computed tomography (SPEC" and a greater likelihood of
partially reversible (Rev) thallium deflects, as indicated by the asterisks
(p < 0 .01) . Other abbreviations as in Figure 1 .
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Figure 4
. Example of matched positron emission
(PET), magnetic resonance (MRI) and thallium-201
positron emission computed (SPECT) tornograms
from a patient with a dilated left ventricle . The flow
image (H 2
`0 [oxygen-labeled water]) at top left is
a functional image of the blood flow measurements
that were calculated in the five myocardial regions
of interest
. The functional flow image shows an
anterolateral region with normal blood flow (arrow)
that manifests reduced "F-fluorodeoxyglucose
(FDG) uptake
. The sarnie territory shows severely
reduced systolic wall thickening in the MRI lomo-
grams and corresponds to a reversible thallium
defect on the SPECT tomograms . Redist = redis-
tribution .
number of partially reversible thallium defects in regions
with reduced '8F-fluorodeoxyglucose uptake compared with
regions with normal "F-fluorodeoxyglucose uptake (42% vs .
18%, respectively, p < 001
: Fig. 3), whereas the number of
totally reversible thallium defects was similar between the
two groups . Twenty-nine regions (23%) with normal "4F-
fluorodeoxyglucose uptake showed mild to moderate irre-
versible thallium defects, with no region manifesting a
severe irreversible thallium defect (Fig . 3). Similarly, 10
regions (23%) with reduced "F-fluorodeoxyglucose uptake
showed irreversible thallium defects ; the irreversible thal-
lium defect was mild to moderate in 9 regions and severe in
only I region (2%) (Fig . 3). Finally, the level of thallium
activity, expressed as the percent of maximal activity mea-
sured in either the redistribution or the reinjection study,
was significantly higher in regions with normal than in
regions with reduced ' 8F-fluorodeoxyglucose uptake (86
13% vs . 73 ± 15%, respectively, p < 0 .01) .
Discussion
The results of the present study indicate that myocardial
regions with normal blood flow and moderately reduced
' 8F-fluorodeoxyglucose uptake occur commonly at rest in
patients with coronary artery disease and left ventricular
dysfunction . This finding was observed in 65% of patients in
our series. These regions correspond to myocardial territo-
ries with a greater impairment of systolic function at rest
than that of regions with normal blood flow and ' 8F-
fluorodeoxyglucose uptake and with a greater extent of
inducible ischemia during exercise .
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. Although the percent of myo-
cardial regions showing normal
systolic
wall thickening at
rest was similar between regions with normal ' xF-
fluorodeoxyglucose uptake and those with reduced lt F-
fluorodeoxyglucose uptake, the percent of regions showing
akinesia or dyskinesia at rest was greater among the regions
with reduced
18F-fluorodeoxyglucose uptake . Thus, the re-
duction in '"F-Ruorodeoxyglucose uptake is frequently as-
sociated with an impairment of regional systolic function
despite the presence of normal blood flow (Fig . 2) . It is
noteworthy that regional systolic function was also impaired
in 45% of the regions with normal blood flow and normal
' 8F-fluorodeoxyglucose uptake, which were either hypoki-
netic or akinetic, indicating that the presence of normal
blood flow at rest may be inaccurate in predicting normal
systolic function in a given myocardial territory . This finding
is not surprising considering the transmural nature of blood
flow measurements obtained by current positron emission
tomographic techniques, and it is in agreement with experi-
mental studies showing a good correlation between suben-
docardial, but not transmural, flow and regional systolic
function (18) . Thus, the presence of very different regional
systolic function among territories with normal blood flow
may be explained by the possibility that subendocardial or
subepicardial ischemia or fibrosis might still exist despite
normal transmural flow, considering the relative contribu-
tions of the subendocardium and the subepicardium to
regional wall thickening (19) .
Regional thallium uptake . The percent of regions with
normal ' 8
F-fluorodeoxyglucose uptake showing normal thal-
lium uptake during exercise (Fig
. 3) was significantly greater
MRI
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than that of regions with reduced ' 8F-fluorodeoxyglucose
uptake (42% vs . 14%)
. Although totally reversible thallium
defects occurred with similar frequency between regions
with normal and those with reduced t8F-fluorodeoxyglucose
uptake, the percent with only partially reversible defects
was significantly greater in regions with reduced 18F-
fluorodeoxyglucose uptake . The frequency of irreversible
thallium defects was similar between the two groups of
18F-fluorodeoxyglucose regions, and all but one of the irre-
versible defects were only mild to moderate in severity .
Previous data indicate that such mild to moderate irrevers-
ible thallium defects correspond to hypoperfused but viable,
rather than nonviable, myocardium (7,10,12,20) .
Mechanism of reduced '$F-fluorodeoxygl
	
uptake in
with normal b flow. Although the cause or
causes of reduced regional f 8F-fluorodeoxyglucose uptake
despite normal blood flow cannot be elucidated from the
present study, some hypotheses can be made. First, the
higher frequency of partially reversible thallium defects in
regions with reduced versus normal 18 F-fluorodeoxyglucose
uptake, su ests the possibility that the former regions
represent a mixture of fibrotic myocardium associated with
jeopardized myocardium capable of developing ischemia
during exercise . The normal transmural blood flow in these
territories is not surprising . Previous observations in dogs
undergoing coronary occlusion and reperfusion have dem-
onstrated that postischemic myocardium, consisting of an
admixture of necrotic tissue interspersed with normal myo-
cardium, shows normal blood flow values (21) . In addition,
as recently reported by Yamamoto et al. (22), the H 2 ' sO
approach used to measure blood flow only measures blood
flow per gram of perfused tissue . This means that, in a
myocardial region consisting of an admixture of necrotic and
normally perfused myocardium, this approach only mea-
sures blood flow to the residual normal myocardium . This
would yield a normal blood flow value in that territory . In
addition, the value measured is independent of the actual
amount of perfused myocardium in that territory and is
therefore not accurate in predicting the functional outcome
after revascularization . This may explain why, as reported
by Yamamoto et al . (22), myocardial blood flow in asynergic
regions showing improved wall motion after revasculariza-
tion did not differ from that measured in irreversibly asyn-
ergic regions . Our data confirm the observations of Ya-
mamoto et al . indicating that normal regional myocardial
blood flow, as measured by the current H, 15 0 approach, is
not always associated with completely normal myocardium
in a given territory. In this regard, the reduced 18F-
fluotodeoxyglucose uptake in myocardial territories with
impaired systolic function, but with "normal" blood flow
values, is consistent with the hypothesis that these territo-
ries represent an admixture of fibrotic myocardium with
severely reduced perfusion and viable myocardium with
normal perfusion.
However, the coexistence of viable and necrotic myocar-
dium in regions with normal blood flow and reduced 18F-
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fluorodeoxyglucose uptake cannot entirely explain ou
present findings because 32% of such myocardial region
demonstrated normal thallium uptake or completely revers
ible thallium defects, suggesting the absence of necroti
myocardium in these territories . In fact, other alternativ
hypotheses can be made to explain the occurrence of norms
flow with reduced B8F-fluorodeoxyglucose uptake . First, th
presence of myocardial stunning would also explain the
coexistence of normal blood flow with impaired systolic
function (23) . Although no patient had a history of recen
myocardial infarction or unstable angina before the stud,
and none reported angina during the study, the possibility o
silent ischemic episodes before the study cannot be rules
out. The available information regarding the metabolic
changes characterizing stunned myocardium are controver
sial : Clinical data suggest that myocardial stunning is also
ciated with enhanced glucose uptake (24-26), whereas ex
perimental data indicate that glucose consumption is
reduced in reperfused stunned myocardium (27) . Therefore
myocardial stunning cannot be ruled out as an explanatioi
for the present observation .
Although in the glucose-loaded state, glucose become:
the predominant myocardial fuel (28,29), accounting for uI
to 1 0 of the myocardial oxygen consumption (29),
preferential use of fatty acids in some myocardial territorie
might represent an additional explanation for the reduces
' 8F-fluorodeoxyglucose uptake in regions with normal blood
flow. However, the association with impaired regional funs
tion and the scintigraphic findings, as well as the nonlocal
ized distribution of these territories throughout the left
ventricle, are evidence against this hypothesis . Likewise, a
true depression of metabolism in these territories cannot be
ruled out from the present data . Future studies to assess the
overall rate of regional oxidative metabolism, perhaps using
' IC-acetate, would be helpful to further address this issue .
Because end-diastolic wall thickness was similar between
regions with normal or reduced ' SF-fluorodeoxyglucose
uptake and no correlation between regional 18F-fluorodeoxy-
glucose uptake and end-diastolic wall thickness was observed,
a partial volume effect is unlikely to have significantly affected
i8F-fluorodeoxyglucose measurements. Nonetheless, the pres-
ence of a significantly more akinetic and dyskinetic regions
in the group with reduced 18F-fluorodeoxyglucose might
have contributed in part to the reduced recovery of 18F-
fluorodeoxyglucose activity in those regions (30) . The find-
ing that regional 18F-fluorodeoxyglucose activity did not
correlate with systolic wall thickening in the current study is
evidence against this possibility. Moreover, in both groups
of regions, with normal and with reduced 18F-fluorodeoxy-
glucose uptake, no difference in 18F-fluorodeoxyglucose
uptake was found between regions with normal or impaired
wall thickening .
The lack of a normal data base to define 18F-fluoro-
deoxyglucose uptake might represent a limitation of the
study. A reduction in 18F-fluorodeoxyglucose uptake in the
septum, compared with the lateral wall, has been reported in
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normal persons under fasting conditions (6) . 11 wever, this
phenomenon is unlikely to explain the present observation .
Under glucose-loaded conditions, the inhomogeneity in glu-
cose uptake becomes minimal, and the septal reduction in
"F-fluorodeoxyglucose uptake does not exceed 13% of the
values observed in the lateral wall (6,31), which is well above
the 20% reduction in "F-fluorodeoxyglucose uptake em-
ployed as a threshold for defining abnormal myocardial
regions in the present study . Moreover, in the present study,
myocardial regions with reduced ' 8F-fluorodeoxyglucose
uptake were localized throughout the entire myocardium,
and only 28% were localized to the septum .
The definition of normal blood flow in the current study is
arbitrary, and this might represent a limitation . In addition,
the use of a fixed threshold value to define normal blood flow
may not entirely reflect the physiology of normal perfusion .
However, the blood flow cutoff value employed was derived
from a previous study (17) reporting a mean blood flow of
0.88 ± 0.08 ml/g per min in a group of normal persons using
positron emission tomography with ' 5O-labeled-carbon di-
oxide . which is almost instantaneously converted in vivo to
1112"0 .
In addition, Bergmann et al . (15), who measured
regional blood flow in a group of normal subjects using
H2150 and dynamic positron emission tomography, reported
a lower limit of normal blood flow value of 0 .67 mllg per
min, similar to our threshold value of 0 .70 ml/g per min .
Finally, in the present study regions with normal ' 8F-
fluorodeoxyglucose uptake showed blood flow similar to that
of regions with reduced "F-fluorodeoxyglucose uptake (Fig .
1) . Hence, the potential inaccuracy caused by an arbitrary
chosen lower limit for normal blood flow and the possibility
that a fixed cutoff may not reflect the physiologic variability
of normal perfusion do not affect the conclusion that the
same blood flow value may be associated with different
functional, metabolic and scintigraphic behavior .
Conclusions. In patients with chronic coronary artery
disease, normal regional blood flow at rest is not always
associated with normal systolic function and with normal
' IF-fluorodeoxyglucose uptake. Compared with findings in
regions with normal blood flow and normal
' 8F-fluorodeoxy-
glucose uptake, a moderate reduction in "F-fluorodeoxy-
glucose uptake in territories with normal blood flow is associ-
ated with a greater frequency of impaired regional systolic
function at rest and a greater frequency of exercise-induced
thallium defects that are only partially reversible. These obser-
vations suggest that the majority of such regions represent an
admixture of fibrotic and reversibly ischemic, jeopardized
myocardium . Consequently, in the individual patient the as-
sessment of myocardial perfusion alone may be inaccurate in
defining myocardial viability because the presence of normal
blood flow in a given myocardial territory does not necessarily
indicate completely normal myocardium in that region .
Whether impaired systolic function associated with normal
blood flow and reduced "F-fluorodeoxyglucose uptake repre-
sents a reversible phenomenon cannot be determined from our
study . Therefore, further studies assessing the effects of revas-
615
cularization in such myocardial territories are needed to define
the impact of the present findings on the clinical management
of patients .
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